Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948129 · ClinicalTrials.gov registry record · NA
Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 626
- Enrollment target
NCT00948129: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00948129 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 626 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948129, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 626 participants
- Enrollment target
Study Summary
This trial studies how well a mobile smoking cessation intervention works in enhancing cancer outreach in low-income adult smokers. Mobile smoking cessation intervention may help smokers quit or cut back on smoking, and help increase the range of cancer prevention services provided to low-income adult smokers.
Primary Outcome
The primary method of analysis will be mixed-model logistic regression.
Interventions
- OTHER Laboratory Biomarker Analysis
- BEHAVIORAL Smoking Cessation Intervention
- OTHER Tobacco Cessation Counseling
- BEHAVIORAL Telephone-Based Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 626 participants |
| Start Date | 2009-08-10 |
| Est. Completion | 2021-02-10 |
| Phase | NA |
What the finished NCT00948129 record still lists
NCT00948129 is an interventional study that assigns participants to a tested intervention. The registered 626 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT00948129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00948129 about?
NCT00948129 is a clinical study titled "Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers". This trial studies how well a mobile smoking cessation intervention works in enhancing cancer outreach in low-income adult smokers. Mobile smoking cessation intervention may help smokers quit or cut back on smoking, and help increase the range of cancer prevention services provided to low-income adu...
What is the current status of trial NCT00948129?
This trial is currently completed. It is a NA study. The enrollment target is 626 participants. The study started on 2009-08-10. Estimated completion is 2021-02-10.
What interventions are being tested in trial NCT00948129?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Smoking Cessation Intervention (BEHAVIORAL), Tobacco Cessation Counseling (OTHER), Telephone-Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00948129?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00948129's enrollment target sits among peer trials
626 160th of 2000 higher than 1,841 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06040827 · 626 participants
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI